MRK · News · 20260912N

Licensing / Collaboration Deals

Merck & Co., Inc. · 2026-09-12 · Importance 13 · Surprise 42

Tempus partnered with Merck on artificial-intelligence-driven precision medicine. The collaboration involves clinical data, medical research, and patient-care applications. The digest does not disclose an upfront payment, milestone obligations, equity investment, or other financial terms.